Synopsis:

Kwality Pharmaceuticals Limited, a Pharma Stock, reports 23.35% YoY revenue growth and a 67.10% YoY net profit surge in Q2 FY26 results.

This Pharma Stock, engaged in the manufacture and export of complex pharmaceutical molecules and finished formulations, including generics, cephalosporins, beta-lactams, oncology, and biologics, jumped 15 percent after the company reported September quarterly results with a 67.10 percent YoY increase in net profit.

With a market capitalization of Rs. 1,021.48 crores, the share of Kwality Pharmaceuticals Limited has reached an intraday high of Rs. 1010.45 per equity share, rising nearly 14.67 percent from its previous day’s close price of Rs. 881.15. Since then, the stock has retreated and is currently trading at Rs. 984.45 per equity shar

See Full Page